These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4674391)

  • 1. [Plasma TSH values in normal subjects and patients with various endocrine disorders].
    Hiroshige N; Kanao K; Inoue M; Sakoda M; Otsuki M
    Nihon Naibunpi Gakkai Zasshi; 1972 Nov; 48(8):569-77. PubMed ID: 4674391
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of a synthetic thyrotrophin releasing hormone (TRH) in normal and endocrinopathic subjects.
    Faglia G; Beck-Peccoz P; Ambrosi B; Ferrari C; Travaglini P
    Acta Endocrinol (Copenh); 1972 Oct; 71(2):209-25. PubMed ID: 4627179
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of the radioimmunoassay of serum thyrotrophin in man.
    Hershman JM; Pittman JA
    Ann Intern Med; 1971 Apr; 74(4):481-90. PubMed ID: 4994544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radioimmunoassay of thyrotropin (TSH) in human plasma].
    Freychet P; Rosselin G; Dolais J
    Presse Med (1893); 1969 Jan; 77(1):13-6. PubMed ID: 5785755
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyroptropin releasing factor (TRF) in patients with pituitary tumors.
    Faglia G; Beck Peccoz P; Ambrosi B; Ferrari C; Neri V
    J Clin Endocrinol Metab; 1971 Dec; 33(6):999-1002. PubMed ID: 5002719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioimmunoassay of serum testosterone--results of the study of normal subjects and patients with endocrine disorders].
    Baba H
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):60-79. PubMed ID: 4734772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)].
    Silvestrini F; Liuzzi A; Chiodini PG; Cattabeni A; Botalla L
    Folia Endocrinol; 1973 Oct; 26(5):398-406. PubMed ID: 4203133
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthyroidism and high serum levels of TSH associated with pituitary tumour.
    Chiarini V; Graziano E; Cremonini N; Frank G; Zampa GA
    Neurochirurgia (Stuttg); 1987 Mar; 30(2):61-3. PubMed ID: 3106846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of human serum thyrotrophin.
    Hall R; Amos J; Ormston BJ
    Br Med J; 1971 Mar; 1(5749):582-5. PubMed ID: 5548300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of synthetic TRH on human prolactin (HPr) secretion].
    Kato Y; Ogo S; Chihara K; Imura H
    Nihon Naibunpi Gakkai Zasshi; 1973 Sep; 49(9):1215-22. PubMed ID: 4201607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Practical value of radioimmunoassay of pituitary thyreotropic hormone].
    Chaussain JL; Job JC
    Ann Endocrinol (Paris); 1972; 33(6):557-70. PubMed ID: 4198751
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.
    Patel YC; Burger HG
    J Clin Endocrinol Metab; 1973 Aug; 37(2):190-6. PubMed ID: 4352630
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of hyperthyroidism due to a chromophobe adenoma.
    Baylis PH
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):145-50. PubMed ID: 1269160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioimmunoassay of plasma H. TSH, II. Results in normal subjects and in pathology].
    Jaquet P; Franchimont P; Rinaldi JP; Sainty JM; Codaccioni JL; Vague J
    Ann Endocrinol (Paris); 1971; 52(4):495-507. PubMed ID: 5171844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further findings on the action of synthetic thyrotropin releasing hormone on the TSH serum level in various endocrine diseases].
    Wagner H; Böckel K; Grote G; Hrubesch M; Vosberg H; Junge-Hülsing G; Hauss WH
    Med Welt; 1972 Oct; 23(41):1419-21. PubMed ID: 4628828
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of serum thyrotropin (TSH) and stimulation with thyrotropin-releasing hormone (TRH) in thyroid diseases.
    Lauridsen UB; Deckert T; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Acta Med Scand; 1974 Sep; 196(3):171-6. PubMed ID: 4214089
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothyroidism secondary to biologically inactive thyroid-stimulating hormone secretion by a pituitary chromophobe adenoma: recovery after removal of the tumor.
    Dickstein G; Barzilai D
    Arch Intern Med; 1982 Aug; 142(8):1544-5. PubMed ID: 7103637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of TRF in the study of pituitary reserve of TSH].
    Cantalamessa L; Reschini E; Giustina G; Miedico D; Valentini F; Beretta F
    Folia Endocrinol; 1973 Feb; 26(1):57-70. PubMed ID: 4633898
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acromegaly and parathyroid adenoma.
    Lamberg BA; Ripatti J; Gordin A; Juustila H; Sivula A; af Björkesten G
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):157-72. PubMed ID: 4308288
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunoassay of thyroid-stimulating hormone and its clinical applications.
    Hall R
    Clin Endocrinol (Oxf); 1972 Jan; 1(1):115-25. PubMed ID: 4200175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.